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Background: M. Suaveolens Ledeb has long been used in China to treat inflammatory infectious diseases. Melilotus
is extracted from Melilotus Suaveolens Ledeb and its therapeutic potential is associated with its anti-inflammatory
activity. However, the precise mechanisms underlying its effects are unknown. This study was conducted to evaluate
the protective effects of melilotus extract in a rat cecal ligation and puncture (CLP)-induced animal model of acute
lung injury (ALI).
Methods: A sepsis model was induced by CLP-like lung inflammation. Two hours prior to CLP administration, the
treatment group was administered melilotus extract via oral injection. RT-PCR and Western blotting were used to
test the expression of cannabinoid receptor (CB)2, NF-κβ and IκB from single peripheral blood mononuclear cells
and lung tissues respectively. Enzyme linked immune sorbent assay was used to detect serum levels of tumor
necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, and IL-12. The numbers of neutrophils, lymphocytes, macrophages
and total cells in the bronchoalveolar lavage (BAL) fluid were counted. For histologic analysis, hematoxylin and
eosin (H&E) stains were evaluated.
Results: After inducing ALI by CLP for 24 hours, melilotus extract up-regulated peripheral blood mononuclear cell
CB2 expression, blocked the activity of NF-κβ65, and the number of neutrophils, lymphocytes and total cells were
significantly lower in the melilotus extract group than the control group. In addition, TNF-α and IL-6 levels were
significantly decreased in the melilotus extract group. Histological results demonstrated the attenuation effect of
melilotus extract on CLP-induced lung inflammation. CB2 was negatively correlated to NF-κβ mRNA and proteins,
respectively (r = −0.377, P < 0.05; r = −0.441, P < 0.05).
Conclusion: The results of this study indicated melilotus extract significantly reduced CLP-induced lung inflammation
by up-regulating CB2 expression. The remarkable protective effects of melilotus extract suggest its therapeutic potential
in CLP induced-acute lung injury treatment.
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Sepsis, a systemic inflammatory response syndrome
(SIRS) induced by infection, is accompanied by the pres-
ence of bacteria or a highly suspicious focus of infection
[1]. SIRS refers to the systematic inflammatory response
leading to a massive, uncontrollable release of inflamma-
tory factors [2]. High levels of inflammatory mediators can* Correspondence: qianchuanyun@126.com
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reproduction in any medium, provided the orlead to the increase of blood capillary permeability and
pulmonary edema, resulting in acute respiratory distress
syndrome, multiple organ failure, high mortality and other
clinical disorders requiring hospitalization. Marijuana
(cannabis sativa), contains Δ9-tetrahydrocannabinol (THC)
as its main active ingredient, and was demonstrated to
inhibit cell growth, have anti-inflammatory effects, and
restrain tumor growth [3]. There are two subtypes of
cannabinoid receptors, CB1 and CB2. CB1 receptors,
mainly located in the brain, spinal cord and peripheral
nervous system, are related to the regulation of memory,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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distributed in the peripheral immune system and are
closely associated with immune regulation and inhibition
of inflammation. Studies indicated that activation of
cannabinoid CB2 receptors could regulate the immune
system and inhibit inflammation [4]. M. suaveolens
Ledeb is an annual or biennial melilotus herbage under
the Leguminosae family, containing a variety of active
ingredients, such as coumarin, flavonoids, phenolic acids,
steroids, triterpene, and carbohydrates [5]. Studies have
shown that M. suaveolens Ledeb is the major efficacious
factor in Leguminosae and is pharmacologically effective
in inhibiting inflammation, alleviating pains, detumes-
cence, increasing blood vessel permeability, antibacter-
ial activity, and antiviral action [6]. However, the
molecular mechanism of the anti-inflammatory effect
of M. suaveolens Ledeb is poorly understood. This study
developed a cecal ligation and puncture (CLP) rat model
of sepsis to observe whether M. suaveolens Ledeb could
promote the expression of CB2 receptors in rats with
sepsis and reduce inflammation, and to determine the
impact of M. suaveolens Ledeb on sepsis-induced lung
injury and its mechanism of action.
Methods
Plant material
M. suaveolens Ledeb was identified by Prof. Chen Ke-Li
(School of Pharmacy, Hubei College of Traditional
Chinese Medicine, Wuhan, China) according to Drug
Standard of Ministry of Health of the People’s Republic
of China (Tibetan Medicine) [7]. Plant materials were
stored in the Plant Specimen Department, School of
Pharmacy, Hubei College of Traditional Chinese Medicine.
Preparation of Melilotus extract from Melilotus
suaveolens Ledeb
Air-dried M. suaveolens Ledeb that grew above ground
(50 g) was powdered and extracted with 70% ethanol at
85°C (3 × 500 ml, 1.5 hours each). Then the extracted
liquid was filtered, combined and concentrated in vacuo.
Subsequently, the liquid was diluted by deionized water
to a concentration of 1 g herb weight per 1 ml water.
Further, 5 ml of the liquid was added into a 100 ml sep-
arator funnel by a 5 ml Mohr measuring pipette for ex-
traction with 10 ml petroleum ether (60°C–90°C), 10 ml
ethyl acetate (EtOAc) and 10 ml n-butanol (BuOH) 6
times for each organic solution, thereby affording a total
dry weight of the ethanol extract (EE) of 7.355 g, petrol-
eum ether fraction (PF) of 0.425 g, EtOAc fraction (EF)
of 1.425 g, BuOH fraction (BF) of 2.425 g and aqueous
fraction (AF) of 3.075 g. Each solution fraction was di-
luted by 1640 medium to an equal concentration of
5 μg/ml (herb weight per solution volume), which was
used to induce CLP-stimulated sepsis.High-performance liquid chromatography (HPLC)
fingerprint to analyze the herb extract
Since coumarin, rutin and hyperoside were reported as
components of the melilotus plant that were anti-
inflammatory [8], they were used as standard substances
to detect the effects of different solution fractions of
ethanol extract from M. suaveolens Ledeb. HPLC finger-
print was used to analyze the ingredients of the herb
extract [9]. Balance (AB204-N, MAX 210 g, d = 0.1 mg,
produced by Merrler Toledo Group) and UV-Detector
(8450/HP, Agilent Science of Life and Chemistry Company)
were used. The HPLC system consisted of a pump
(model DIONEX P680 HPLC Pump, ASI-100 to form a
high pressure gradient) with Automated Sample Injector
facility, Chromeleon management system and UV–VIS
(UVD 170U) model detector. The column was Kromasil
C-18 (250 × 4.6 mm, 10 nm-5 mm, Hanbon Science &
Technology Co., Ltd). Chromatography conditions in-
cluded: a gradient elution of acetonitrile and 0.05% H3PO4
of 1.0 ml min−1 flow rate; a 5 ml capacity per injection
was used with the UV detector at four wavelengths:
220 nm for coumarin, 254 ± 2 nm, 275 nm coumarin and
rutin and 363 nm for hyperoside; the reference concen-
trations for coumarin, rutin and hyperoside were
0.007648 mg ml−1, 0.2548 mg ml−1 and 0.2528 mg m−1,
respectively. The column was placed in a column oven
set at 25°C. Then the petroleum ether subfraction was
filtered through a 0.45 mm filter membrane (Hanbon
Science & Technology Co, Ltd) and stored in a refriger-
ator before use. The multi-step gradient elution was
carried out with acetonitrile and 0.05% H3PO4 solu-
tion. The procedure was as follows: 0–8 min (5%
acetonitrile, 95% H3PO4 solution), 8–25 min (5–30%
acetonitrile, 95–70% H3PO4 solution), 25–35 min
(30% acetonitrile, 70% H3PO4 solution), 35–60 min
(30–70% acetonitrile, 70–30% H3PO4 solution), 60–
70 min (30%-5% acetonitrile, 70–95% H3PO4 solution)
and 70–80 min (5% acetonitrile, 95% H3PO44 solution).Animals
Male Sprague Dawley rats were purchased from Kunming
Medical University Laboratory Animal Center (Kunming,
China). All rats were housed in the Kunming Medical
University animal care facility and were maintained under
pathogen-free conditions. Rats were 8–9 weeks of age
at the initiation of the experiments and were maintained
on standard laboratory chow and water ad libitum. All
experiments were approved and conducted in accord-
ance with the guidelines of the Animal Care Committee
of Kunming Medical University. The experimental pro-
cedures were approved by the Ethics Committee of the
Institute of Yunan University of Traditional Chinese
Medicine (TCM).
Table 1 Primer sequences for genes to RT-PCR validation
of microarray analysis
CB2 mRNA F-5′-GTTCATCGCCTTCCT- 3′ 415 bp
R-5′-CTCGGGGCTTCTTCTTTTG-3′
NF-κB mRNA F-5′ -GCACGGATGACAGAGGCGTGTATAAGG-3′ 420 bp
R-5′-GGCGGATGATCTCCTTCTCTCTGTCTG-3′
IκB mRNA F-5′-TGCTGAGGCACTTCTGAG-3′ 421 bp
R-5′- CTGTATCCGGGTGCTTGG -3′
β-actin F-5′-GATTACTGCTCTGGCTCCTGC-3′ 190 bp
R-5′-GACTCATCGTACTCCTGCTTGC-3′
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Trizol kit was purchased from Gibco, USA; reverse tran-
scription (RT) reaction kit was obtained from Takara
Biotechnology Co. Ltd, (Dalian, China); PCR Amplification
Reagent Kit and the DNA ladder Marker was acquired
from Sangon Biological Engineering Co. Ltd. (Shanghai,
China); β-actin was from Santa Cruz Biotechnology, Inc.
(USA); TNF-α, IL-6, IL-10 and IL-12 enzyme linked im-
mune sorbent assay (ELISA) kits were from Science and
Technology Development Center of the People’s Liberation
Army General Hospital, Beijing, China.
Animal model and group
According to a random number table, 80 rats were ran-
domly divided into 4 groups: normal control group,
sham operation group (sham group), sepsis model group
(model group) and melilotus treatment group (treatment
group), with 20 rats in each group. The sepsis model
was induced by CLP. Briefly, animals were deprived of
food, but water was permitted for 6 h prior to surgery.
Under light ether anesthesia, a laparotomy was per-
formed through a midline abdominal incision. The
cecum was punctured twice at different sites with an
18-gauge needle and gently compressed until faces were
extruded. The bowel was then returned to the abdomen
and the abdominal incision was closed in 2 layers. Ani-
mals in the model and treatment groups were treated
with 5 ml/100 g body weight of normal saline subcuta-
neously at the completion of surgery to provide replace-
ment for the extracellular fluid sequestered during
peritonitis. Animals in the sham group received sham
operation where the cecum was not ligated or punc-
tured. Two hours before surgery, animals in the treat-
ment group received melilotus extract (25 mg/kg) once
every eight hours, and the normal control, sham and
control groups were given the same volume of saline.
Sample preparations
After animals in each group were anesthetized with
ether at 24 h, the right internal carotid artery was iso-
lated. Blood was extracted (5 ml), centrifuged to collect
the supernatant, dispensed into two sterile tubes, sealed
with sealing glue, and placed in a freezer at −20°C until
used. Extracted peripheral venous blood (2 ml) was
placed in EDTA anticoagulant tubes, and peripheral
blood mononuclear cells (PBMC) were isolated by Ficoll
density gradient centrifugation to detect CB2 expression.
All the animals were euthanized 24 h after surgery and
samples were collected for further tests.
RT-PCR analysis
Lung tissue and mononuclear cells were homogenized in
TRIzol reagent (Invitrogen) using Mixer 301. Total RNA
was extracted according to the manufacturer’s protocol.RNA samples were electrophoresed in agarose gels and
visualized with ethidium bromide for quality control.
Three micrograms of RNA were reverse transcribed with
reverse transcriptase for 1 h at 37°C to synthesize cDNA.
Quantitative changes in mRNA expression were assessed
by real-time quantitative Real-Time PCR. The PCR mas-
ter mix contained 0.5 U of Taq polymerase, 1 μL of each
primer and 2 μL of each cDNA sample in a final volume
of 25 μL. All amplifications were repeated three times.
Oligonucleotide primer sequences are shown in Table 1.
β2-actin was used as an endogenous control, and each
sample was normalized on the basis of its β2-actin con-
tent. Relative quantification of mRNA expression levels
of target genes was calculated using the 2-ΔΔCt method.
Western blot analysis
Lung tissue and mononuclear cells were homogenized in
modified RIPA buffer. Equal amounts of protein (15 μg)
were loaded into a 12.5% SDS-polyacrylamide mini-gel,
followed by electrophoresis. Protein samples were mixed
with sample buffer, boiled for 10 min, separated by SDS-
PAGE under denaturing conditions, and electroblotted
to nitrocellulose membranes. The blots were incubated
overnight in Tris buffered saline (TBS) containing 5%
milk to block nonspecific binding of the antibody. Pro-
teins of interest were revealed with specific antibodies
as indicated (1:1000 dilution) for 1 h at room temperature
followed by incubation with a 1:5000 dilution of
horseradish peroxidase-conjugated polyclonal anti-rabbit
antibody for 1 h at room temperature. Signals were visual-
ized by chemiluminescence. Equal protein loading of the
samples was confirmed by β-actin. All western blots were
quantified using densitometry.
Myeloperoxidase (MPO) activity determination
MPO activities were determined using an MPO kit pro-
duced by Jiancheng Bioengineering Institute (Nanjing,
China) according to the manufacturer’s instructions. In
brief, frozen samples of lung were thawed and homoge-
nized in ice-cold buffer provided in the kit. The homog-
enates were centrifuged at 5000 × g for 10 min. Pellets
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bromide in 50 mM PBS (pH 6.0) and incubated at 60°C
for 2 h. After another centrifugation, supernatants were
collected. Their protein concentrations were measured
using a protein assay kit (A045, Jiancheng Bioengineer-
ing Institute). In a 96-well plate, 15 μg protein was incu-
bated with 100 μl 3,3R,5,5R-tetramethylbenzidine for
3 min. After 100 μl sulfuric acid (1 N) was added,
absorbance was read by a spectrophotometer at a wave-
length of 450 nm. Original MPO values were normalized
with protein contents.
Determination of levels of inflammatory cells in
bronchoalveolar lavage fluid (BAL)
A tracheotomy was performed in 25% urethane-anes
thetized animals, by inserting a 5 mm plastic tube, and
repeating lavage five times with saline and a gauze
filter. Samples were immediately stored at 4°C until fur-
ther processing within 2 hours of the BAL procedure.
BAL fluid was strained through a monolayer of surgical
gauze to remove mucus. An aliquot was reserved for
total cell counts. The total cell number was counted
using a Nageofte’s chamber, and results were expressed
as cells × 103/ml. The remaining fluid was immediately
centrifuged at 800 × g for 10 mm at 4°C and the cell
pellet was washed twice with phosphate-buffered saline
solution (without Ca++ and Mg++). Cytocentrifugates
(Labofuge, AE Meraeus, FRG) were stained using the
May-Grunwald-Giemsa method. The differential cell
count of macrophages, lymphocytes, neutrophils and
eosinophils was made under light microscopy at × 1000
magnification, by counting approximately 300 cells in
random fields. Because only a few mast cells were
present and difficult to detect using the May-Grunwald-
Giemsa stain, they were counted in cell suspension after
staining with Alcian blue-safranine. Mast cells were quan-
tified by counting 1,000 cells. Results were expressed as
the number of cells × 106/L of recovered fluid.
Cytokine measurement in serum
TNF-α, IL-12, IL-6, IL-4, and IL-10 serum levels of rats
was measured by ELISA according to the manufacturer’s
instructions (R&D Systems).
Histopathologic examination of lung tissue
Lungs from all four groups were excised at 24 h follow-
ing the challenge dose of endotoxin. The lungs were
fixed with 100% ethanol intratracheally under 20 cm of
H2O pressure. After fixation, lungs were embedded in
paraffin, cut into 5-μm sections, and stained with
hematoxylin and eosin (HE). Lung sections were evalu-
ated and scored independently by 2 members of the
study group trained in histological assessment and use
of the scoring system. For each mouse, 3 different lobeswere examined for the following features: interstitial
edema, hemorrhage, and neutrophil infiltration. Each
feature was scored as follows: 0 (no injury), 1 (minimal
injury), 2 (moderate injury), or 3 (severe injury). This
was totaled to provide an individual lobe score, and the
mean of the 3 lobes was used to generate a score for
each mouse, giving a minimum score of 0 and a max-
imum of 9.
Survival Curves
Another 45 rats were divided into sham operation
group, CLP group, and CLP plus melilotus extract group
(n = 15 per group) to observe survival. The treatments
were the same as for the previous experiments. Observa-
tion was begun at the time of melilotus extract treat-
ment, while the endpoint was set at 120 hours after
melilotus extract treatment.
Statistical analysis
SPSS 11.0 software was used for statistical analysis of the
results. Data were expressed as the mean ± SD. Statistical
differences between the two groups were evaluated by
analysis with t-test; analysis of linear correlation was
used to evaluate the correlation between two variances;
q-test of analysis of variance (ANOVA) was used to
analyze multiple comparison. Survival data were ana-
lyzed utilizing log-rank or χ2. Values of P < 0.05 were
accepted as indicating significance.
Results
HPLC fingerprint of ethanol extract from M. suaveolens
Ledeb
HPLC fingerprint analysis (Figure 1) shows M. suaveolens
Ledeb EtOAc fraction had coumarin (retention time was
33.225 min), but no hyperoside or rutin (retention times
were 24.535 min and 25.407 min, respectively). Thus, cou-
marin might be an anti-inflammatory compound present
in the M. suaveolens Ledeb EtOAc fraction, and changes
in coumarin content in different intervention liquids could
explain their different effects (Tables 2 and 3). Coumarin
was chosen as a reference peak in HPLC fingerprint
analysis and the relative retention time (RT) and relative
area (RA,%) of the EtOAc fraction of ethanol extract were
calculated (Table 4). In addition, this data suggested the
M. suaveolens Ledeb EtOAc fraction mainly contained
lower polar compounds including coumarin.
Effect of melilotus extract on the expression of CB2 in
mononuclear cells in peripheral blood, NF-κβ, and IκB in
lung tissue by RT-PCR and western blotting
PT-PCR and western blotting were used to measure the
expressions of CB2, NF-κβ and IκB within single PBMC
and lung tissues. RT-PCR and western blot analysis
found that the expression of CB2 and IκB was markedly
Table 2 Contents of coumarin in different analytical





Ethanol extract (EE) 12 11.4990
Petroleum ether fraction (PF) 150 42.0393
EtOAc fraction (EF) 75 48.6013
BuOH fraction (BF) 150 3.4989
Aqueous fraction (AF) 150 0
Coumarin 0.0075
Table 3 Contents of coumarin in different intervention
liquids (n = 3)
Sample Concentration of intervention
liquid (ng/ml)
Ethanol extract (EE) 4.891
Petroleum ether fraction (PF) 1.4110
EtOAc fraction (EF) 3.1902
BuOH fraction (BF) 0.1096
Aqueous fraction (AF) 0
Coumarin
Figure 1 HPLC fingerprint of the EtOAc fraction of M. suaveolens Ledeb at 220 nm (A), 254 nm (B), 275 nm (C) and 363 nm (D).
(Note: line 1 represents blank control of EtOAc solvent, line 2 represents standard substances of coumarin, line 3 represents rutin and line 4 represents
rutin and hyperoside).
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Table 4 RT and RA (%) of various peaks in analytical
liquid HPLC fingerprint
RT 0.429 0.695 0.729 0.810 0.870 1.000 1.580 1.803
RA (%) 2.300 2.839 3.197 30.713 3.841 51.104 4.001 1.897
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regulated after CLP. After melilotus extract therapy, the
expression of CB2 and Iκβ was markedly enhanced, while
NF-κβ expression was significantly lowered. Therefore,
melilotus extract could suppress the expression of NF-κβ,
and up-regulate CB2 and IκB expression (Figures 2 and 3).
A negative correlation existed between CB2 mRNA and
NF-κβ mRNA as well as between CB2 and NF-κβ
(r = −0.377, P < 0.05; r = −0.441, P < 0.05) (Figure 4).Figure 2 Effect of melilotus extract on the expression of CB2 mRNA i
mRNA from lung tissue. A): Representative RT-PCR showing the level of C
tubed administration of melilotus extract. 1: mark; 2: normal control group; 3:
summary of the densitometric analysis of CB2 mRNA, NF-κβ mRNA and Iκ
determined from three independent experiments. *P < 0.05, **P < 0.01, vs the
vs the control group.Effect of melilotus extract on levels of TNF-α, IL-6, IL-10,
IL-4, and IL-12 in serum
Serum TNF-α, IL-6, IL-12, IL-4, and IL-10 levels were
increased significantly in CLP-induced rats. After ad-
ministration with melilotus extract, the levels of proin-
flammatory cytokines (TNF-α, IL-12 and IL-6) were
significantly decreased, while levels of anti-inflammatory
cytokines (IL-10 and IL-4) were markedly increased
(Figure 5).
Effect of melilotus extract on MPO activity in lung tissue
After cecal ligation and puncture operation, MPO
activity in lung tissue was obviously increased. After
administration with melilotus extract, MPO activity
was significantly decreased (Figure 6).n mononuclear cells from peripheral blood, NF-κβ mRNA and IκB
B2 mRNA, NF-κβ mRNA and Iκβ mRNA expression in rats at 24 h after
sham operation group; 4: control group; 5: treatment group. B): Statistical
β mRNA expression in rats. Each value represents the mean ± SD as
normal control group and sham operation group; #P < 0.05, ##P < 0.01,
Figure 3 Effect of melilotus extract on the expression of CB2 in mononuclear cells in peripheral blood, NF-κβ and Iκβ in lung tissue by
western blot. A): Representative western blots show the level of CB2, NF-κβ and Iκβ expression in rats at 24 h after tubed administration of
melilotus extract. 1: normal control group; 2: sham operation group; 3: control group; 4: treatment group. B): Statistical summary of the densitometric
analysis of CB2, NF-κβ and Iκβ expression in rats. Data represent the mean ± SD of 3 experiments. *P < 0.05, **P < 0.01, vs the sham operation group;
##P < 0.01, #P < 0.01, vs the control group.
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cells in BAL fluid
The total inflammatory cell, macrophage, neutrophil,
lymphocyte and monocyte counts in BAL fluid in
the CLP group were obviously increased. After meli-
lotus extract treatment, the total inflammatory cell,
macrophage, neutrophil, lymphocyte and monocyte
counts in BAL fluid were significantly decreased
(Figure 7).Figure 4 Change in correlation between CB2 and NF-κβ mRNA and p
mRNA and NF-κβ mRNA expression. B): Statistical summary of correlation b
used to evaluate the correlation between CB2 and NF-κβ mRNA and prote
as well as between CB2 and NF-κβ protein (r = −0.377, P < 0.05; r = −0.441,Effect of melilotus extract on histopathologic changes of
lung tissue
There was no sign of hemorrhage, edema and inflamma-
tory cell infiltration in lung tissue in the normal and
sham groups. After CLP, hemorrhage, edema and infil-
tration of inflammatory cells were observed in lung tis-
sues, and acute lung injury (ALI) pathology scores were
significantly enhanced compared with the model group.
In contrast, injury to lung tissue was alleviated in therotein expression. A): Statistical summary of correlation between CB2
etween CB2 and NF-κβ expression. Analysis of linear correlation was
in. A negative correlation exists between CB2 mRNA and NF-κβ mRNA
P < 0.05).
Figure 5 Effect of melilotus extract on the levels of TNF-α, IL-6, IL-10, IL-4, and IL-12 in plasma. Plasma TNF-α, IL-4, IL-6, IL-10 and IL-12
levels were measured by ELISA. The data represent the means ± SD (n = 20, pg/L) from triplicate experiments. **P < 0.01, *P < 0.05, vs the sham
operation group; #P < 0.05, ##P < 0.01, vs the control group.
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were significantly reduced (treatment group) (Figure 8).
Effect of melilotus extract on survival of sepsis rats
The survival of rats was markedly decreased in rats re-
ceiving CLP compared to the control group. The de-
creased survival induced by CLP was significantly
attenuated by post-treatment with melilotus extract as
compared to the CLP-induced alone group (Figure 9).
Discussion
Abundant evidence shows that CLP-induced sepsis with
acute suppurative peritonitis is a typical sepsis model
with G-bacteria as the predominant infection source [6].
The CLP sepsis model is highly stable, repetitive, and ap-
plicable, thus it is currently regarded as the “golden
standard” for sepsis-related studies. This model, by
virtue of cecal ligation and perforation, leads to the
pollution of the abdominal cavity by bacteria-carrying
intestinal contents, gives rise to generalized peritonitis,
and induces a wide range of systemic inflammatoryFigure 6 Effect of melilotus extract on MPO levels in lung
tissues. MPO activities were determined using an MPO kit. Data are
expressed as the mean ± SD as determined from three independent
experiments. **P<0.01, vs the sham operation group; #P<0.05, vs the
control group.responses [10]. Furthermore, model animals initially
demonstrate clinical effects resembling high power cycle
and high metabolism, and a low power cycle state at
later stages. Thus, it is regarded as the sepsis model with
the strongest clinical relevance [11]. Previous studies
showed that approximately 18–72 h after cecum ligation
perforation, rats exhibit lung injury, low-oxygen, neutro-
phil cell infiltration, and alveoli and interstitial edema
[12]. Therefore, the CLP animal model of rats with
sepsis was used in this study.
Marijuana has been used for medicine for thousands
of years. Δ9-THC is the major active constituent of
marijuana. As proposed by Kunos, [13] multiple canna-
binoid receptors have been demonstrated throughout
the body, but only CB1 and CB2 are commonly studied.
CB1 is mainly expressed in the brain, spinal cord and
peripheral nervous system, mainly related to the regula-
tion of memory, cognition, and motion control; while
CB2 does not exist in the central nervous system [14],
but instead is distributed in the peripheral immune sys-
tem, including B cells, natural killer cells, monocytes,
macrophages, neutrophils, dendritic cells, mast cells and
T cells [15]. Studies have shown that CB2 receptors are
mainly involved in the in vivo immune response and can
inhibit inflammation. The major actions are as follows:
(1) inhibition of endothelial cell inflammatory responses
[16]; (2) inhibition of monocyte migration and inflamma-
tory cytokine release [9]; (3) inhibition of proliferation and
migration of vascular smooth muscle; and (4) inhibition of
the proliferation of T cell activation [17]. For example, the
selective CB2 receptor stimulant AM1241 can act on CB2
receptors on peripheral immune cells, inhibiting the re-
lease of inflammatory factors and easing pain [18]. Im-
portantly, CB2 agonists do not induce side effects in the
central nervous system. CB2 receptors can regulate B cell
and T cell differentiation as well as the balance between
the proinflammatory and anti-inflammatory effects of
Thl/Th2 helper T cells. The activation of CB2 receptors
Figure 7 Effect of melilotus extract on inflammatory cells in BAL fluid. TC: total inflammatory cells, MAC: macrophages, N: neutrophils, L:
lymphocytes, MON: monocytes. Inflammatory cell counts are expressed as the mean ± SD (n = 20, × 106/L) as determined from three
independent experiments. **P < 0.01; vs the sham operation group; #P < 0.05, ##P < 0.01, vs the control group.
Figure 8 Histopathological changes of lung tissues in rats (a→ d, HE staining, ×100 magnification; e→ h HE staining, ×400 magnification.
A): Histopathological changes in lung tissues from rats a: normal control group, b: sham operation group, c: control group, d: treatment group,
e: normal control group, f: sham operation group; g: control group, h: treatment group. B): Statistical summary of ALI pathology score in rats. ALI
pathology scores were expressed as the mean ± SD from triplicate experiments. **P < 0.01; vs the sham operation group; ##P < 0.01; vs the
control group.
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Figure 9 Survival curve. CLP group: group challenged with CLP; CLP +melilotus extract groups: group challenged with CLP and treated with
melilotus extract. *P < 0.05, vs sham operation group. #P < 0.05; vs CLP group.
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release of proinflammatory cytokines TNF-α, nitric oxide,
and IL-12p40 [16]. Rajesh et al. [18] found that JWH-133,
a specific CB2 receptor activator, inhibited TNF-α-
induced expression of intercellular adhesion molecule-1,
vascular cell adhesion molecule 1, macrophage chemotac-
tic protein-1, signaling pathway activation of nuclear fac-
tor, and the migration of monocytes to arterial endothelial
cells. In the current study, increased CB2 expression
inhibited NF-κβ expression, reduced the produce of proin-
flammatory factors (TNF-α and IL-6), decreased MPO
production and the accumulation of inflammatory cells,
and significantly alleviated lung injury.
It was shown that through involvement in the tran-
scription of a variety of cytokine genes, NF-κβ could
exert a complicated impact on the regulating network.
Activated NF-κβ can enhance the transcription of many
cytokines, such as TNF-α and IL-1, [19], to lengthen the
synthesizing time and quantity of inflammation factors
[20]. Inhibition of NF-κβ activity can decrease the ex-
pression of inflammatory media regulated by NF-κβ, and
reduce the infiltration and activation of inflammatory
cells, thus protecting lung tissues from damage [21]. IκB
also has a critical role in the transcription and expres-
sion of inflammatory factors regulated by NF-κβ [22].
The current study indicates that inhibition of NF-κβ
expression or promotion of IκB expression can both be
conducive to the reduction of proinflammatory factors
(TNF-α and IL-6), the generation of anti-inflammatory
media (IL-10 and IL-12), the inhibition of accumulation
of inflammatory cells, production of MPO within the
lung, and alleviation of lung damage.
As a traditional Chinese medicine, M. suaveolens
Ledeb is an annual or biennial melilotus herbage under
the Leguminosae family. It tastes bitter and cold, and
is functional in heat-clearing and detoxifying, anti-
inflammation and detumescence. Thus, it can be appliedto splenic disease, twisted intestinal fever, diphtheria,
and tonsillitis amongst others [23]. Pharmaceutical study
results indicated M. suaveolens Ledeb contains several
substances such as coumarin, flavonoids, phenolic acids,
and saponins with anti-inflammatory and anti-bacterial
properties [23]. HPLC fingerprint analysis of the herb
extract showed that the only content of petroleum ether
extract from M. suaveolens Ledeb was coumarin.
Pharmacological studies showed that melilotus extract
tablets reduced vascular permeability, enhanced capillary
strength, inhibited loss of serum proteins, maintained
normal colloid osmotic pressure, reduced leakage, and
had a diuretic effect by inhibiting renal tubular reabsorp-
tion of sodium and chlorine [24], thus alleviating or
eliminating inflammation and edema [25]. In addition,
they could promote protein decomposition in tissues,
activate protein hydrolysis of macrophages, reduce pro-
tein concentration, reduce osmotic pressure, and pro-
mote lymphatic circumfluence [26], thus reducing tissue
edema. Moreover, these factors could effectively inhibit
the biosynthesis and release of inflammatory factors
such as opioid peptides and β-endorphin to alleviate
inflammation, which, therefore, has obvious anti-
inflammatory and analgesic effects. Asres K, et al. [27]
used a granulation swelling experiment to confirm that
both melilotus suaveolens extract and melilotus suaveo-
lens preparations have powerful anti-inflammatory effects.
Plesca-Manea et al. [28] demonstrated that extracts from
melilotus suaveolens with 0.25% coumarin and hydro-
cortisone sodium were similarly effective as anti-
inflammatory agents. The anti-inflammation effect may
be attributed to the reducing effects of melilotus sua-
veolens extract on the activation of phagocytic cells
and generation of citrulline. Ritschel et al. [29] showed
that intravenous injection of 12.5–100 mg/kg of coumarin
to rats had dose-related anti-inflammatory and detu-
mescence effects. Furthermore, subcutaneous injection
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induced edema in rats. In vitro studies have shown that
different extracts and coumarin from melilotus suaveolens
can inhibit lipopolysaccharide stimulation of RAW264.7
cells to generate proinflammatory factors, such as IL-6,
TNF-α, IL-1β, and NO, and can improve the generation
of the anti-inflammatory factor, IL-10 [30]. Thus, it can
be seen from this study that melilotus suaveolens can
promote the expression of CB2, inhibit the expression of
NF-κβ, increase Iκβ expression, reduce the generation of
proinflammatory factors (TNF-α, IL-12, and IL-6), in-
crease the production of anti-inflammatory factors (IL-10
and IL-4), inhibit MPO production and the accumulation
of inflammatory cells within the lung, and alleviate lung
injury. Therefore, melilotus suaveolens can inhibit inflam-
matory cell invasion and significantly alleviate lung injury,
thus having a protective role for lungs.
Conclusions
In summary, this study clearly demonstrated the anti-
inflammatory effect of melilotus extract via increased canna-
binoid CB2 receptor activation. Moreover, melilotus extract
blocked CLP-induced NF-κβ expression and up-regulated
Iκβ expression, inhibited MPO production. It also reduced
the accumulation of inflammatory cells within the lung, and
alleviated the pathological injury of lung tissues in rats with
sepsis, which provides an animal experimental basis for the
treatment of sepsis by application ofM. suaveolens Ledeb.
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